Correlation Between ChemoMetec and Wirtek AS
Can any of the company-specific risk be diversified away by investing in both ChemoMetec and Wirtek AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec and Wirtek AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and Wirtek AS, you can compare the effects of market volatilities on ChemoMetec and Wirtek AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec with a short position of Wirtek AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec and Wirtek AS.
Diversification Opportunities for ChemoMetec and Wirtek AS
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ChemoMetec and Wirtek is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and Wirtek AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wirtek AS and ChemoMetec is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with Wirtek AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wirtek AS has no effect on the direction of ChemoMetec i.e., ChemoMetec and Wirtek AS go up and down completely randomly.
Pair Corralation between ChemoMetec and Wirtek AS
Assuming the 90 days trading horizon ChemoMetec AS is expected to generate 1.28 times more return on investment than Wirtek AS. However, ChemoMetec is 1.28 times more volatile than Wirtek AS. It trades about 0.23 of its potential returns per unit of risk. Wirtek AS is currently generating about -0.48 per unit of risk. If you would invest 43,260 in ChemoMetec AS on September 20, 2024 and sell it today you would earn a total of 5,040 from holding ChemoMetec AS or generate 11.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ChemoMetec AS vs. Wirtek AS
Performance |
| Timeline |
| ChemoMetec AS |
| Wirtek AS |
ChemoMetec and Wirtek AS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ChemoMetec and Wirtek AS
The main advantage of trading using opposite ChemoMetec and Wirtek AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec position performs unexpectedly, Wirtek AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wirtek AS will offset losses from the drop in Wirtek AS's long position.| ChemoMetec vs. Dataproces Group AS | ChemoMetec vs. cBrain AS | ChemoMetec vs. Nilfisk Holding AS | ChemoMetec vs. Danish Aerospace |
| Wirtek AS vs. ChemoMetec AS | Wirtek AS vs. Ambu AS | Wirtek AS vs. Genmab AS | Wirtek AS vs. Zealand Pharma AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |